<DOC>
	<DOCNO>NCT00908583</DOCNO>
	<brief_summary>To determine deletional strategy provide effective desensitization .</brief_summary>
	<brief_title>Desensitization Kidney Transplantation</brief_title>
	<detailed_description>A prospective iterative trial proteasome inhibitor ( PI ) -based therapy reduce HLAantibody ( Ab ) level conduct five phase differ bortezomib dose density plasmapheresis timing . Phases include 1 2 bortezomib cycle ( 1.3mg/m2,6-8 dos ) , one rituximab dose plasmapheresis . HLA Abs measure solid phase flow cytometry ( FCM ) assay . Immunodominant Ab ( iAb ) define high HLA Ab level . Forty-four patient receive 52 desensitization course ( 7 patient enrolled multiple phase ) : Phase 1 ( n=20 ) , Phase 2 ( n=12 ) , Phase 3 ( n=10 ) , Phase 4 ( n=5 ) , Phase 5 ( n=5 ) .</detailed_description>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Age 18 65 Voluntary write informed consent Patient decease donor wait list current peak cytotoxic calculate panel reactive antibody ( PRA ) &gt; 20 % Myocardial infarction within 6 month Patient receive investigational drug within 14 day prior initiation study treatment Serious medical psychological illness Diagnosed malignancy within three year , except complete research basal cell carcinoma squamous cell carcinoma skin , insitu malignancy low risk prostate cancer curative therapy Absolute neutrophil count ( ANC ) &lt; 1000 Receipt live vaccine within 4 week study entry Female subject breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Alloantibody</keyword>
	<keyword>Desensitization</keyword>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Nephrology</keyword>
	<keyword>Plasma Cells</keyword>
	<keyword>Translational Research/Science</keyword>
</DOC>